Armando Santoro

Armando Santoro

UNVERIFIED PROFILE

Are you Armando Santoro?   Register this Author

Register author
Armando Santoro

Armando Santoro

Publications by authors named "Armando Santoro"

Are you Armando Santoro?   Register this Author

100Publications

2683Reads

27Profile Views

Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND).

Future Oncol 2019 Dec 20;15(35):4009-4017. Epub 2019 Nov 20.

Medical Oncology & Hematology Unit, Humanitas Cancer Center, Humanitas Clinical & Research Center, IRCCS, Rozzano, Milan, 20089, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0480DOI Listing
December 2019

Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question.

Br J Radiol 2019 Dec 18:20190627. Epub 2019 Dec 18.

Department of Biomedical Sciences, Humanitas University, Rozzano-Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1259/bjr.20190627DOI Listing
December 2019

Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report.

Medicine (Baltimore) 2019 Dec;98(50):e18089

Department of Medical Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano (MI).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000018089DOI Listing
December 2019

Cabozantinib for the treatment of hepatocellular carcinoma.

Expert Rev Anticancer Ther 2019 Oct 11;19(10):847-855. Epub 2019 Oct 11.

Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, IRCCS , Rozzano, Milan , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1674141DOI Listing
October 2019

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma.

Liver Int 2019 Aug 3;39(8):1468-1477. Epub 2019 Jun 3.

National Institute of Gastroenterology, Research Instituts "S. De Bellis" Research Hospital, Castellana Grotte, Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.14113DOI Listing
August 2019

Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience.

Immunotherapy 2019 08 14;11(11):945-952. Epub 2019 Jun 14.

Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2019-0029DOI Listing
August 2019

PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.

Eur J Nucl Med Mol Imaging 2019 Jul 26;46(7):1468-1477. Epub 2019 Mar 26.

Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-019-04313-8DOI Listing
July 2019

Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer.

Future Oncol 2019 Jun 4;15(18):2107-2112. Epub 2019 Jun 4.

Humanitas Cancer Center, Humanitas Clinical & Research Center, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0904DOI Listing
June 2019

Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma.

Leuk Lymphoma 2019 May 15;60(5):1204-1213. Epub 2018 Oct 15.

h Division of Hematology , Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan , Milan , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1519808DOI Listing
May 2019

Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?

Crit Rev Oncol Hematol 2019 Mar 30;135:66-75. Epub 2019 Jan 30.

UO of Medical Oncology, Dept of Oncology Hematology, Humanitas Clinical Research Hospital Rozzano, Italy; Medical School, Humanitas University, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.01.016DOI Listing
March 2019

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.

Clin Colorectal Cancer 2018 09 21;17(3):e489-e498. Epub 2018 Mar 21.

Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2018.03.010DOI Listing
September 2018

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top".

Cancer Treat Rev 2018 Sep 21;69:121-131. Epub 2018 Jun 21.

Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy; Humanitas Cancer Center, Humanitas Research Hospital, Rozzano, MI, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.06.016DOI Listing
September 2018

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment.

Acta Neurochir (Wien) 2018 09 3;160(9):1779-1787. Epub 2018 Jul 3.

Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Rozzano (Milan), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00701-018-3599-4DOI Listing
September 2018

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.

World J Surg 2018 08;42(8):2651-2659

Department of Surgery - Division of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center - IRCCS, Humanitas University, Via Manzoni 56, 20089, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00268-018-4525-xDOI Listing
August 2018

Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.

Oncology 2018 23;94 Suppl 1:19-28. Epub 2018 Jul 23.

Department of Medical Oncology and Hematology, Humanitas Cancer Center and Research Hospital, IRCCS, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000489065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193748PMC
July 2018

Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?

Ann Surg Oncol 2018 Jun 27;25(6):1676-1685. Epub 2018 Feb 27.

Division of Hepatobiliary and General Surgery, Department of Surgery, Humanitas Clinical and Research Center - IRCCS, Humanitas University, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-6387-8DOI Listing
June 2018

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications.

Drugs Context 2018 27;7:212533. Epub 2018 Jun 27.

Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Via Manzoni 56, 20089 Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7573/dic.212533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038776PMC
June 2018

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.

J Clin Oncol 2018 05 27;36(14):1428-1439. Epub 2018 Mar 27.

Philippe Armand and Margaret A. Shipp, Dana-Farber Cancer Institute, Boston, MA; Andreas Engert, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas Cancer Center, Humanitas University, Milan; Pier Luigi Zinzani, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy; John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Winship Cancer Institute, Emory University, Atlanta, GA; Jan Paul De Boer, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands, on behalf of Lunenburg Lymphoma Phase I/II Consortium; John Kuruvilla, University of Toronto and Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, BC Cancer Agency, Vancouver, British Columbia, Canada; Marek Trneny, Charles University, General Hospital in Prague, Prague, Czech Republic; Kazunobu Kato, Anne Sumbul, and Benedetto Farsaci, Bristol-Myers Squibb, Princeton, NJ; and Stephen M. Ansell, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.0793DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075855PMC
May 2018

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

Radiother Oncol 2018 Apr 29;127(1):108-113. Epub 2017 Dec 29.

Radiotherapy and Radiosurgery Department, Humanitas Cancer Center and Research Hospital, Rozzano, Italy; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2017.12.006DOI Listing
April 2018

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.

J Clin Oncol 2018 04 2;36(10):942-950. Epub 2018 Feb 2.

Margaretha G.M. Roemer, Robert A. Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Philippe Armand, Donna S. Neuberg, and Margaret A. Shipp, Dana-Farber Cancer Institute; Geraldine S. Pinkus, Azra H. Ligon, and Scott J. Rodig, Brigham and Women's Hospital, Boston, MA; Margaretha G.M. Roemer, VU University Medical Center; Jan Paul De Boer, Antoni van Leeuwenhoek Hospital, Lunenburg Phase I/II Consortium, Amsterdam, the Netherlands; Stephanie Sasse, University Hospital of Cologne, Cologne, Germany; Anas Younes, Memorial Sloan Kettering Cancer Center, New York, NY; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Armando Santoro, Humanitas University, Rozzano, Milan; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; John Timmerman, University of California, Los Angeles Medical Center, Los Angeles, CA; Graham P. Collins, Churchill Hospital, Oxford, United Kingdom; Radhakrishnan Ramchandren, Barbara Ann Karmanos Cancer Institute, Detroit, MI; Jonathon B. Cohen, Emory University, Atlanta, GA; John Kuruvilla, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Kerry J. Savage, British Columbia Cancer Agency Center for Lymphoid Cancer, Vancouver, British Columbia, Canada; Marek Trneny, Charles University in Prague, General University Hospital in Prague, Prague, Czech Republic; Stephen Ansell, Mayo Clinic, Rochester, MN; and Kazunobu Kato, Benedetto Farsaci, and Anne Sumbul, Bristol-Myers Squibb, Princeton, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.3994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877802PMC
April 2018

Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?

Immunotherapy 2018 04;10(5):403-410

Department of Oncology & Hematology, Humanitas Clinical & Research Center, Rozzano (MI), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0151DOI Listing
April 2018

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

J Clin Oncol 2018 02 14;36(4):342-349. Epub 2017 Dec 14.

Paolo Andrea Zucali, Matteo Simonelli, Matteo Perrino, Fabio De Vincenzo, Laura Giordano, Monica Bertossi, Annarita Destro, Luca Di Tommaso, and Armando Santoro¸ Humanitas Clinical and Research Hospital; Tommaso De Pas, Francesca Toffalorio, Fabio Conforti, and Angela Cioffi, European Institute of Oncology; Paolo Andrea Zucali, Matteo Simonelli, Luca Di Tommaso, and Armando Santoro, Humanitas University, Milan; Giovannella Palmieri, Vincenzo Damiano, Margaret Ottaviano, and Sabino De Placido, Università Federico II, Naples; Adolfo Favaretto and Giulia Pasello, Istituto Oncologico Veneto, Padua; Antonio Chella and Erika Garbella, University Hospital, Pisa; Marcello Tiseo, Azienda Ospedaliero-Universitaria of Parma, Parma; and Michele Caruso and Marco Ali, Humanitas Centro Catanese di Oncologia, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.4078DOI Listing
February 2018

Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.

Mediterr J Hematol Infect Dis 2018 15;10(1):e2018013. Epub 2018 Feb 15.

Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2018.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841938PMC
February 2018

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.

J Clin Oncol 2017 Dec 4;35(35):3898-3905. Epub 2017 Oct 4.

Martin Dreyling, Ludwig Maximilians University of Munich, Munich; Georg Lenz, University Hospital Münster, Münster; Marius Giurescu, Karl Köchert, Henrik Seidel, and Florian Hiemeyer, Bayer AG, Berlin, Germany; Armando Santoro, Humanitas Clinical and Research Center, Rozzano; Pier Luigi Zinzani, University of Bologna, Bologna, Italy; Luigina Mollica, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada; Sirpa Leppä, Helsinki University Central Hospital Cancer Center, Helsinki, Finland; George A. Follows, Addenbrooke's Hospital, Cambridge, United Kingdom; Won Seog Kim, Samsung Medical Center, Seoul, South Korea; Arnon Nagler, Tel Aviv University, Tel HaShomer, Israel; Panayiotis Panayiotidis, National and Kapodistrian University of Athens, Athens, Greece; Judit Demeter, Semmelweis University, Budapest, Hungary; Muhit Özcan, Ankara University School of Medicine, Ankara, Turkey; Marina Kosinova, Kemerovo Regional Clinical Hospital, Kemerovo, Russian Federation; Krimo Bouabdallah, University Hospital of Bordeaux, Pessac; Franck Morschhauser, Hôpital Claude Huriez, Lille, France; Don A. Stevens, Norton Cancer Institute, Louisville, KY; David Trevarthen, Comprehensive Cancer Care and Research Institute of Colorado, Englewood, CO; and Lisa Cupit, Li Liu, Carol Peña, Shuxin Yin, Jose Garcia-Vargas, and Barrett H. Childs, Bayer HealthCare Pharmaceuticals, Whippany, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.4648DOI Listing
December 2017

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.

Br J Haematol 2017 12 19;179(5):748-755. Epub 2017 Oct 19.

Neuromuscular and Neuroimmunology Service, Department of Medical Biotechnology and Translational Medicine, Milan University, Humanitas Clinical and Research Hospital IRCCS, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14966DOI Listing
December 2017

Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis.

Anticancer Res 2017 12;37(12):7057-7062

Radiotherapy and Radiosurgery, Humanitas Cancer Center and Research Hospital, Rozzano-Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12177DOI Listing
December 2017

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come.

Ecancermedicalscience 2017 30;11:787. Epub 2017 Nov 30.

Humanitas Research Hospital, Medical Oncology, Via Manzoni 56, 20089 Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2017.787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718252PMC
November 2017

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

J Neurooncol 2017 Oct 8;135(1):129-139. Epub 2017 Jul 8.

Neurosurgical Oncology Department, Humanitas Cancer Center and Research Hospital, Via Manzoni, 56 20089, Rozzano (Milan), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-017-2559-9DOI Listing
October 2017

Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!

J Clin Oncol 2017 07 4;35(19):2213-2214. Epub 2017 May 4.

Nicola Personeni, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano; and University of Milan, Milan, Italy; Lorenza Rimassa and Laura Giordano, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy; and Armando Santoro, Humanitas Cancer Center, Humanitas Clinical and Research Center; and Humanitas University, Rozzano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.7776DOI Listing
July 2017

Regorafenib for the treatment of unresectable hepatocellular carcinoma.

Expert Rev Anticancer Ther 2017 07 9;17(7):567-576. Epub 2017 Jun 9.

a Medical Oncology and Hematology Unit, Humanitas Cancer Center , Humanitas Clinical and Research Center , Rozzano ( Milan ), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1338955DOI Listing
July 2017

Imatinib mesylate in desmoplastic small round cell tumors.

Future Oncol 2017 Jun 7;13(14):1233-1237. Epub 2017 Jun 7.

Department of Medical Oncology & Hematology - Humanitas Cancer Center IRCCS, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2016-0305DOI Listing
June 2017

Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature.

Crit Rev Oncol Hematol 2017 May 29;113:283-291. Epub 2017 Mar 29.

Department of Medical Oncology, IRCCS Humanitas Clinical and Research Institute, Rozzano, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.03.013DOI Listing
May 2017

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.

J Neurooncol 2017 01 8;131(2):377-384. Epub 2016 Nov 8.

Radiotherapy and Radiosurgery, Humanitas Cancer Center and Research Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-016-2310-yDOI Listing
January 2017

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

Immunotherapy 2016 12;8(12):1363-1369

Humanitas Cancer Center, Humanitas Clinical & Research Center, Via Manzoni 56, 20089 Rozzano (Mi), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0057DOI Listing
December 2016

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

Crit Rev Oncol Hematol 2016 Nov 21;107:1-13. Epub 2016 Aug 21.

Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, 20089 Rozzano (Mi), Italy; Humanitas University, Rozzano Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.08.005DOI Listing
November 2016

Aromatase inhibitors in premenopause: Great expectations fulfilled?

Crit Rev Oncol Hematol 2016 Nov 28;107:82-89. Epub 2016 Aug 28.

Dept of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Hospital, Humanitas University, Viale Manzoni 56, 20089 Rozzano, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.08.009DOI Listing
November 2016

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

J Clin Oncol 2016 Oct;34(30):3627-3637

Matteo G. Della Porta, Anna Gallì, Silvia Zibellini, Ettore Rizzo, Marianna Rossi, Marta Ubezio, Virginia V. Ferretti, Silvia Catricalà, Chiara Milanesi, Emilio P. Alessandrino, and Mario Cazzola, Fondazione IRCCS Policlinico, San Matteo; Matteo G. Della Porta, Alberto Malovini, Ivan Limongelli, Riccardo Bellazzi, and Mario Cazzola, University of Pavia, Pavia; Andrea Bacigalupo, Maria Teresa van Lint, Sarah Pozzi, and Silvia Luchetti, San Martino Hospital, Genova; Massimo Bernardi, Cristina Tresoldi, and Fabio Ciceri, San Raffaele Scientific Institute; Paola Marenco and Laura Pezzetti, Ospedale Niguarda Ca' Granda, Milan; Bernardino Allione and Benedetto Bruno, University of Torino, Torino; Pietro Pioltelli, Ospedale San Gerardo, Monza; Alberto Bosi, Azienda Ospedaliera Universitaria Careggi, Florence; Maria Teresa Voso and Simona Sica, Catholic University of the Sacred Heart, Rome; Mariella Cuzzola, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria; Emanuele Angelucci, Ospedale Oncologico di Riferimento Regionale A. Businco, Cagliari; Orietta Spinelli and Alessandro Rambaldi, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo; Francesca Bonifazi, University of Bologna, Bologna; Armando Santoro, Humanitas University, Rozzano, Italy; Alberto Riva, University of Florida, Gainesville, FL; and Elli Papaemmanuil, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.3616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366344PMC
October 2016

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

J Clin Oncol 2016 09 5;34(27):3293-9. Epub 2016 Jul 5.

Armando Santoro, Rita Mazza, Luca Castagna, Laura Giordano, and Carmelo Carlo-Stella, Humanitas Cancer Center; Armando Santoro, Humanitas University, Rozzano; Alessandro Pulsoni and Giorgia Annechini, Sapienza University, Rome; Alessandro Re, Antonella Anastasia, and Annalisa Peli, Spedali Civili, Brescia; Maurizio Bonfichi and Manuel Gotti, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia; Vittorio Ruggero Zilioli, Niguarda Ca' Granda Hospital; Carmelo Carlo-Stella, University of Milano, Milan; Flavia Salvi, SS Antonio e Biagio Hospital, Alessandria; Francesco Merli, Arcispedale S. Maria Nuova/IRCCS, Reggio Emilia; Stefano Luminari, University of Modena and Reggio Emilia, Modena; Anna Marina Liberati, A.O. Santa Maria, Terni; and Nicola Di Renzo, Vito Fazzi Hospital, Lecce, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.4466DOI Listing
September 2016